<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://wiki.esonto.de/index.php?action=history&amp;feed=atom&amp;title=In_vitro_Tyrosine_Kinase_Activity_Assay</id>
	<title>In vitro Tyrosine Kinase Activity Assay - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.esonto.de/index.php?action=history&amp;feed=atom&amp;title=In_vitro_Tyrosine_Kinase_Activity_Assay"/>
	<link rel="alternate" type="text/html" href="https://wiki.esonto.de/index.php?title=In_vitro_Tyrosine_Kinase_Activity_Assay&amp;action=history"/>
	<updated>2026-04-17T21:02:21Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.esonto.de/index.php?title=In_vitro_Tyrosine_Kinase_Activity_Assay&amp;diff=97&amp;oldid=prev</id>
		<title>ESO wikiadmin: Created page with &quot;{| class=&quot;wikitable&quot; |+ !Materials ! |- | |Kinase buffer (125 mM NaCl; 48 mM MgCl&lt;sub&gt;2&lt;/sub&gt;; 50 mM HEPES (pH 7.5)  |- | |4x SDS Buffer |- | |1 mM ATP |- | |Purified Kinase (e.g. Src or FAK) |- | |Kinase substrate (e.g. CEACAM3-cytoplasmic domain or FAK substrate) |}  === Procedure === ----  * 0.2 μg/ml FAK-substrate or 25 ng/μl TwinStrep-Ceacam3-cytoplasmic domains * 0.2 μg/ml hFAK KD (recombinant human FAK kinase domain) or 10 ng/μl Src * with or without (control)...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.esonto.de/index.php?title=In_vitro_Tyrosine_Kinase_Activity_Assay&amp;diff=97&amp;oldid=prev"/>
		<updated>2025-02-27T12:08:37Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;{| class=&amp;quot;wikitable&amp;quot; |+ !Materials ! |- | |Kinase buffer (125 mM NaCl; 48 mM MgCl&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;; 50 mM HEPES (pH 7.5)  |- | |4x SDS Buffer |- | |1 mM ATP |- | |Purified Kinase (e.g. Src or FAK) |- | |Kinase substrate (e.g. CEACAM3-cytoplasmic domain or FAK substrate) |}  === Procedure === ----  * 0.2 μg/ml FAK-substrate or 25 ng/μl TwinStrep-Ceacam3-cytoplasmic domains * 0.2 μg/ml hFAK KD (recombinant human FAK kinase domain) or 10 ng/μl Src * with or without (control)...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Materials&lt;br /&gt;
!&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|Kinase buffer (125 mM NaCl; 48 mM MgCl&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;; 50 mM HEPES (pH 7.5) &lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|4x SDS Buffer&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|1 mM ATP&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|Purified Kinase (e.g. Src or FAK)&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|Kinase substrate (e.g. CEACAM3-cytoplasmic domain or FAK substrate)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Procedure ===&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
* 0.2 μg/ml FAK-substrate or 25 ng/μl TwinStrep-Ceacam3-cytoplasmic domains&lt;br /&gt;
* 0.2 μg/ml hFAK KD (recombinant human FAK kinase domain) or 10 ng/μl Src&lt;br /&gt;
* with or without (control) 100 μM ATP&lt;br /&gt;
* in kinase buffer in a total volume of 30 μl/sample.&lt;br /&gt;
* Kinase reactions are incubated at 37°C on an Eppendorf Thermomixer under constant mixing for 1h.&lt;br /&gt;
* The kinase reaction is stopped by addition of 10 µl pre-heated 4 x SDS buffer and the samples are denatured for 5 min at 96 °C.&lt;br /&gt;
* After centrifugation, the sample is loaded on a SDS-PAGE gel and processed for sequential Western Blotting with:&lt;br /&gt;
* primary mouse α-pY (detecting tyrosine phosphorylated substrate)&lt;/div&gt;</summary>
		<author><name>ESO wikiadmin</name></author>
	</entry>
</feed>